Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 357

1.

Type conversion of secretomes in a 3D TAM2 and HCC cell co-culture system and functional importance of CXCL2 in HCC.

Lu Y, Li S, Ma L, Li Y, Zhang X, Peng Q, Mo C, Huang L, Qin X, Liu Y.

Sci Rep. 2016 Apr 27;6:24558. doi: 10.1038/srep24558.

2.

Cytochrome P450 1A2 Metabolizes 17β-Estradiol to Suppress Hepatocellular Carcinoma.

Ren J, Chen GG, Liu Y, Su X, Hu B, Leung BC, Wang Y, Ho RL, Yang S, Lu G, Lee CG, Lai PB.

PLoS One. 2016 Apr 19;11(4):e0153863. doi: 10.1371/journal.pone.0153863. eCollection 2016.

3.

Inflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathways.

Echizen K, Hirose O, Maeda Y, Oshima M.

Cancer Sci. 2016 Apr;107(4):391-7. doi: 10.1111/cas.12901. Epub 2016 Mar 18. Review.

4.

IL-6 Inhibition Reduces STAT3 Activation and Enhances the Antitumor Effect of Carboplatin.

Wang ZY, Zhang JA, Wu XJ, Liang YF, Lu YB, Gao YC, Dai YC, Yu SY, Jia Y, Fu XX, Rao X, Xu JF, Zhong J.

Mediators Inflamm. 2016;2016:8026494. doi: 10.1155/2016/8026494. Epub 2016 Mar 2.

5.

Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients.

Gu XQ, Zheng WP, Teng DH, Sun JS, Zheng H.

World J Gastroenterol. 2016 Mar 7;22(9):2749-59. doi: 10.3748/wjg.v22.i9.2749. Review.

6.

The role of HIF-1 in oncostatin M-dependent metabolic reprogramming of hepatic cells.

Battello N, Zimmer AD, Goebel C, Dong X, Behrmann I, Haan C, Hiller K, Wegner A.

Cancer Metab. 2016 Feb 17;4:3. doi: 10.1186/s40170-016-0141-0. eCollection 2016.

7.

Genetic polymorphisms of C-reactive protein increase susceptibility to HBV-related hepatocellular carcinoma in a Guangxi male population.

Lao X, Ren S, Lu Y, Yang D, Qin X, Li S.

Int J Clin Exp Pathol. 2015 Dec 1;8(12):16055-63. eCollection 2015.

8.

A new HIF-1α/RANTES-driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF in mice.

Koh MY, Gagea M, Sargis T, Lemos R Jr, Grandjean G, Charbono A, Bekiaris V, Sedy J, Kiriakova G, Liu X, Roberts LR, Ware C, Powis G.

Hepatology. 2016 May;63(5):1576-91. doi: 10.1002/hep.28468. Epub 2016 Mar 7.

PMID:
26799785
9.

Estrogen receptor α in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor microenvironment.

Yeh CR, Slavin S, Da J, Hsu I, Luo J, Xiao GQ, Ding J, Chou FJ, Yeh S.

Mol Cancer. 2016 Jan 20;15:7. doi: 10.1186/s12943-015-0488-9.

10.

MiR-17~92 ablation impairs liver regeneration in an estrogen-dependent manner.

Zhou Y, Zhang L, Ji H, Lu X, Xia J, Li L, Chen F, Bu H, Shi Y.

J Cell Mol Med. 2016 May;20(5):939-48. doi: 10.1111/jcmm.12782. Epub 2016 Jan 19.

11.

Roles of low-density lipoprotein receptor-related protein 1 in tumors.

Xing P, Liao Z, Ren Z, Zhao J, Song F, Wang G, Chen K, Yang J.

Chin J Cancer. 2016 Jan 6;35(1):6. doi: 10.1186/s40880-015-0064-0.

12.

EGFR Signaling in Liver Diseases.

Komposch K, Sibilia M.

Int J Mol Sci. 2015 Dec 29;17(1). pii: E30. doi: 10.3390/ijms17010030. Review.

13.

A basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemness.

Kim T, Yang SJ, Hwang D, Song J, Kim M, Kyum Kim S, Kang K, Ahn J, Lee D, Kim MY, Kim S, Seung Koo J, Seok Koh S, Kim SY, Lim DS.

Nat Commun. 2015 Dec 16;6:10186. doi: 10.1038/ncomms10186.

14.

Menopausal hormone therapy use and risk of primary liver cancer in the clinical practice research datalink.

McGlynn KA, Hagberg K, Chen J, Braunlin M, Graubard BI, Suneja N, Jick S, Sahasrabuddhe VV.

Int J Cancer. 2016 May 1;138(9):2146-53. doi: 10.1002/ijc.29960. Epub 2015 Dec 31.

PMID:
26662112
15.

Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Compensates for Interleukin-6 in Initial B Cell Activation.

Sin SH, Kang SA, Kim Y, Eason A, Tan K, An H, Dittmer DP.

J Virol. 2015 Dec 9;90(4):2150-4. doi: 10.1128/JVI.02456-15.

PMID:
26656696
16.

New Approaches for Studying Alcoholic Liver Disease.

Xu J, Liu X, Gao B, Karin M, Tsukamoto H, Brenner D, Kisseleva T.

Curr Pathobiol Rep. 2014 Dec;2(4):171-183. Epub 2014 Sep 14.

17.

IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome.

Palumbo GA, Scisciani C, Pediconi N, Lupacchini L, Alfalate D, Guerrieri F, Calvo L, Salerno D, Di Cocco S, Levrero M, Belloni L.

PLoS One. 2015 Nov 18;10(11):e0142599. doi: 10.1371/journal.pone.0142599. eCollection 2015. Erratum in: PLoS One. 2015;10(12):e0145555.

18.

Transposon mouse models to elucidate the genetic mechanisms of hepatitis B viral induced hepatocellular carcinoma.

Chiu AP, Tschida BR, Lo LH, Moriarity BS, Rowlands DK, Largaespada DA, Keng VW.

World J Gastroenterol. 2015 Nov 14;21(42):12157-70. doi: 10.3748/wjg.v21.i42.12157. Review.

19.

Hepatocyte-Specific Arid1a Deficiency Initiates Mouse Steatohepatitis and Hepatocellular Carcinoma.

Fang JZ, Li C, Liu XY, Hu TT, Fan ZS, Han ZG.

PLoS One. 2015 Nov 16;10(11):e0143042. doi: 10.1371/journal.pone.0143042. eCollection 2015.

20.

Summary of the 2014 Alcohol and Immunology Research Interest Group (AIRIG) meeting.

Hammer AM, Morris NL, Cannon AR, Shults JA, Curtis B, Casey CA, Sueblinvong V, Persidsky Y, Nixon K, Brown LA, Waldschmidt T, Mandrekar P, Kovacs EJ, Choudhry MA.

Alcohol. 2015 Dec;49(8):767-72. doi: 10.1016/j.alcohol.2015.09.002. Epub 2015 Oct 8.

PMID:
26520175
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk